000 | 01970 a2200553 4500 | ||
---|---|---|---|
005 | 20250517201853.0 | ||
264 | 0 | _c20190130 | |
008 | 201901s 0 0 eng d | ||
022 | _a1097-6744 | ||
024 | 7 |
_a10.1016/j.ahj.2017.11.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHwang, Doyeon | |
245 | 0 | 0 |
_aEfficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease. _h[electronic resource] |
260 |
_bAmerican heart journal _c03 2018 |
||
300 |
_a103-112 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCoronary Restenosis _xetiology |
650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
650 | 0 | 4 |
_aMyocardial Ischemia _xcomplications |
650 | 0 | 4 | _aOutcome Assessment, Health Care |
650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xcomplications |
650 | 0 | 4 |
_aRepublic of Korea _xepidemiology |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aStroke _xepidemiology |
700 | 1 | _aPark, Kyung Woo | |
700 | 1 | _aLee, Joo Myung | |
700 | 1 | _aRhee, Tae-Min | |
700 | 1 | _aHong, Myeong-Ki | |
700 | 1 | _aJang, Yangsoo | |
700 | 1 | _aValgimigli, Marco | |
700 | 1 | _aColombo, Antonio | |
700 | 1 | _aGilard, Martine | |
700 | 1 | _aPalmerini, Tullio | |
700 | 1 | _aStone, Gregg W | |
700 | 1 | _aKim, Hyo-Soo | |
773 | 0 |
_tAmerican heart journal _gvol. 197 _gp. 103-112 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2017.11.013 _zAvailable from publisher's website |
999 |
_c28090029 _d28090029 |